查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1830907

2025年綜合多重診斷全球市場報告

Syndromic Multiplex Diagnostics Global Market Report 2025
出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10個工作天內

價格
簡介目錄

近年來，症候群多重診斷市場快速擴張，市場規模從2024年的31.1億美元成長至2025年的34.3億美元，複合年成長率達10.0%。推動這一成長的因素包括：對快速精準診斷的需求不斷成長、人們對早期疾病檢測的認知不斷提高、醫院內感染發病率不斷上升、分子診斷的廣泛應用、醫療保健支出不斷成長以及對就地檢驗的需求不斷成長。

預計未來幾年綜合症多重診斷市場規模將強勁成長，到 2029 年將達到 49.6 億美元，複合年成長率為 9.7%。預測期內的成長可歸因於研發投資的增加、資源匱乏環境中採用率的提高、開發中國家醫療基礎設施的擴大、政府抗擊感染疾病的舉措的增多以及對分散式檢查的需求的增加。預測期內的主要趨勢包括多重聚合酵素鏈鎖反應(PCR) 技術的進步、微流體和實驗室晶片系統的創新、樣品處理自動化程度的提高、照護現場分子平台的開發、雲端基礎的診斷數據系統的整合以及攜帶式診斷設備的進步。

症候群多重診斷是一種分子檢測方法，可從單一患者樣本同時檢測和鑑定與特定症候群相關的多種病原體或生物標記。此方法採用多重聚合酵素鏈鎖反應(PCR) 或同等技術，提供快速且全面的結果。透過一次性識別多種潛在病因，這些診斷方法有助於及時準確地診斷感染疾病，從而改善臨床決策和患者預後。

症候群多重診斷的主要產品類型包括儀器、試劑、軟體和服務。症候群多重診斷設備是先進的分子檢測系統，旨在使用即時聚合酵素鏈鎖反應(PCR) 和微流體等整合平台同時檢測單一患者樣本中的多種病原體，從而快速準確地診斷疾病。分析的樣本類型包括血液、尿液、唾液和組織。這些診斷方法採用多種技術，包括聚合酵素鏈鎖反應(PCR)、質譜、核酸增幅檢查和次世代定序，並應用於感染疾病、性行為感染和中樞神經系統疾病等領域。最終用戶包括臨床實驗室、醫院、製藥和生物技術公司以及研究機構。

2025年春季美國關稅的突然上調以及隨之而來的貿易摩擦對醫療設備行業產生了重大影響，尤其對進口診斷影像設備零件、手術用不銹鋼和塑膠耗材產生了重大影響。醫院和診所抵制漲價，擠壓了製造商的淨利率。監管障礙加劇了這個問題，因為與關稅相關的供應商變更通常需要設備重新認證，從而延緩了產品上市時間。企業正在透過雙重採購關鍵零件、擴大國內商品化生產以及加快具成本效益材料的研發來降低風險。

本研究報告是商業研究公司 (The Business Research Company) 新報告系列的一部分，該系列提供症候群多重診斷市場統計數據，例如全球市場規模、區域佔有率、症候群多重診斷市場佔有率的競爭對手、詳細的症候群多重診斷細分市場、市場趨勢以及症候群多重診斷行業的商機，為您提供在症候群多重診斷行業取得成功所需的數據。本症候群多重診斷市場研究報告對該行業的現狀和未來情況進行了詳細分析，為您提供所需的一切資訊的完整展望。

預計感染疾病多重診斷率的上升將在未來幾年推動症候群多重診斷市場的成長。當細菌、病毒、真菌和寄生蟲等有害微生物侵入人體並在體內繁殖時，就會發生感染疾病，從而引起各種症狀和健康併發症。感染疾病的增加主要是由於全球旅行的增加，這促進了病原體跨境和跨人群傳播。症候群多重診斷透過從單一樣本中快速同時檢測多種病原體來支持感染疾病管理。這些診斷方法提高了診斷的速度和準確性，從而能夠及時做出治療決策並改善患者的預後。例如，2023 年 3 月，美國國家公共衛生機構疾病管制與預防中心報告 2022 年有 8,331 例結核病病例，比 2021 年的 7,874 例增加了 5.9%。因此，感染疾病的增加促進了症候群多重診斷市場的擴張。

症候群多重診斷領域的主要企業正專注於開發技術先進的解決方案，包括基於人工智慧的診斷演算法，以提高病原體檢測的速度、準確性和廣度。基於人工智慧的診斷演算法是一種先進的計算工具，它利用人工智慧（尤其是機器學習和深度學習技術）分析複雜的臨床和實驗室數據，從而更快、更準確地診斷疾病。例如，2024年1月，總部位於荷蘭的分子診斷公司Qiagen NV為其QIAstat-Dx平台推出了兩種症候群檢測組合：胃腸道組合2和腦膜炎和腦炎組合。這些組合可以在一次檢測中快速準確地檢測多種病原體，從而輔助臨床決策並改善患者預後。 QIAstat-Dx系統還整合了先進的數據分析功能，幫助醫護人員有效率地識別和管理感染疾病疫情。

2022年6月，總部位於德國的生技公司R Biopharm AG收購了AusDiagnostics Pty Ltd.，收購金額未揭露。 R Biopharm旨在透過此次收購擴大產品系列，進軍新的臨床診斷細分市場，加速其國際成長策略，並成為全球公認的跨地區臨床實驗室診斷系統供應商。 AusDiagnostics Pty Ltd.總部位於澳大利亞，專注於體外診斷（IVD）和綜合多重診斷。

症候群多重診斷市場由提供診斷工作流程整合服務、遠端檢測、用於症候群檢測的臨床決策支援工具以及診斷實驗室的法規和合規性支援等服務的營業單位所獲得的收益構成。市場價值包括服務供應商銷售的或包含在其服務產品中的相關產品的價值。症候群多重診斷市場還包括用於同時檢測多種病原體的多重診斷儀器、試劑、耗材、軟體和配件的銷售。此市場的價值代表“出廠價”，即產品製造商或創造者向其他營業單位（包括下游製造商、批發商、經銷商和零售商）或直接向最終客戶銷售的產品價值。該市場中的產品價值還包括產品創造者銷售的任何相關服務。

目錄

第1章執行摘要

第2章 市場特徵

第3章 市場趨勢與策略

第4章 市場：宏觀經濟情景，包括利率、通膨、地緣政治、貿易戰和關稅，以及新冠疫情和復甦對市場的影響

第5章 全球成長分析與策略分析框架

  • 全球症候群多重診斷：PESTEL分析（政治、社會、科技、環境、法律因素、促進因素與限制因素）
  • 最終用途產業分析
  • 全球症候群多重診斷市場：成長率分析
  • 全球症候群多重診斷市場表現：規模與成長，2019-2024
  • 全球症候群多重診斷市場預測：規模與成長，2024-2029 年，2034 年
  • 全球症候群多重診斷：總目標市場（TAM）

第6章 市場細分

  • 全球症候群多重診斷市場（依產品類型、績效及預測），2019-2024 年、2024-2029 年、2034 年
  • 裝置
  • 試劑
  • 軟體和服務
  • 全球症候群多重診斷市場（依樣本類型、實際及預測），2019-2024 年、2024-2029 年、2034 年
  • 血液樣本
  • 尿液樣本
  • 唾液樣本
  • 組織樣本
  • 全球症候群多重診斷市場：依技術、績效與預測，2019-2024 年、2024-2029 年、2034 年
  • 聚合酵素鏈鎖反應
  • 質譜法
  • 核酸增幅檢查
  • 次世代定序
  • 全球症候群多重診斷市場：依應用、績效及預測，2019-2024 年、2024-2029 年、2034 年
  • 感染疾病
  • 呼吸系統疾病
  • 消化系統疾病
  • 性行為感染傳染病
  • 中樞神經系統疾病
  • 全球綜合症多重診斷市場：按最終用戶、實際和預測，2019-2024 年、2024-2029 年、2034 年
  • 臨床實驗室
  • 醫院
  • 製藥和生物技術公司
  • 研究機構
  • 其他最終用戶
  • 全球症候群多重診斷市場：依設備類型細分，實際及預測，2019-2024 年、2024-2029 年、2034 年
  • 即時聚合酵素鏈鎖反應（PCR）系統
  • 基於微流體的系統
  • 自動化樣本到答案系統
  • 基於墨盒的系統
  • 多重聚合酵素鏈鎖反應（PCR）平台
  • 全球症候群多重診斷市場：按試劑類型、效能和預測細分，2019-2024 年、2024-2029 年、2034 年
  • 檢測組
  • 引子和探針
  • 酵素
  • 緩衝液和溶液
  • 樣品製備試劑
  • 全球症候群多重診斷市場：按軟體和服務細分（按類型）、實際和預測，2019-2024 年、2024-2029 年、2034 年
  • 數據分析軟體
  • 雲端基礎的診斷平台
  • 整合和連接解決方案
  • 技術支援服務
  • 維護和校準服務
  • 培訓及安裝服務

第7章 區域和國家分析

  • 全球症候群多重診斷市場：按地區、績效及預測，2019-2024 年、2024-2029 年、2034 年
  • 全球症候群多重診斷市場：國家、績效及預測（2019-2024 年、2024-2029 年及 2034 年）

第8章 亞太市場

第9章：中國市場

第10章 印度市場

第11章 日本市場

第12章：澳洲市場

第13章 印尼市場

第14章 韓國市場

第15章：西歐市場

第16章英國市場

第17章：德國市場

第18章：法國市場

第19章：義大利市場

第20章：西班牙市場

第21章 東歐市場

第22章俄羅斯市場

第23章 北美市場

第24章美國市場

第25章：加拿大市場

第26章 南美洲市場

第27章：巴西市場

第28章 中東市場

第29章：非洲市場

第30章：競爭格局與公司概況

  • 症候群多重診斷市場：競爭格局
  • 症候群多重診斷市場：公司簡介
    • Roche Molecular Systems Inc. Overview, Products and Services, Strategy and Financial Analysis
    • Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
    • Becton Dickinson and Company Overview, Products and Services, Strategy and Financial Analysis
    • Hologic Inc. Overview, Products and Services, Strategy and Financial Analysis
    • Bio-Rad Laboratories Inc. Overview, Products and Services, Strategy and Financial Analysis

第31章：其他領先和創新企業

  • Qiagen NV
  • Cepheid
  • Bosch Healthcare Solutions GmbH
  • Biocartis NV
  • Luminex Corporation
  • Curetis GmbH
  • Accelerate Diagnostics Inc.
  • Applied BioCode Inc.
  • Ador Diagnostics Ltd.
  • Akonni Biosystems Inc.
  • Alveo Technologies Inc.
  • Atlas Genetics Ltd.
  • BioFire Diagnostics LLC
  • Nanomix Inc.
  • Primerdesign Ltd.

第 32 章全球市場競爭基準化分析與儀表板

第33章 重大併購

第34章近期市場趨勢

第 35 章：高潛力市場國家、細分市場與策略

  • 2029年症候群多重診斷市場：提供新機會的國家
  • 2029年症候群多重診斷市場：細分市場帶來新機會
  • 2029年症候群多重診斷市場：成長策略
    • 基於市場趨勢的策略
    • 競爭對手策略

第36章 附錄

簡介目錄
Product Code: r37898

Syndromic multiplex diagnostics is a molecular testing approach that simultaneously detects and identifies multiple pathogens or biomarkers linked to a particular syndrome from a single patient sample. This approach employs multiplex polymerase chain reaction (PCR) or comparable technologies to provide rapid and comprehensive results. By identifying multiple potential causes at once, these diagnostics support timely and accurate diagnosis of infectious diseases, enhancing clinical decision-making and patient outcomes.

The primary product categories in syndromic multiplex diagnostics include instruments, reagents, software, and services. Syndromic multiplex diagnostic instruments are sophisticated molecular testing systems designed to detect multiple pathogens simultaneously from a single patient sample, using integrated platforms such as real-time polymerase chain reaction (PCR) or microfluidics for fast and precise disease diagnosis. The types of samples analyzed include blood, urine, saliva, and tissue. These diagnostics employ various technologies, including polymerase chain reaction (PCR), mass spectrometry, nucleic acid amplification tests, and next-generation sequencing, and are applied in areas such as infectious diseases, respiratory diseases, gastrointestinal diseases, sexually transmitted infections, and central nervous system diseases. Their end users include clinical laboratories, hospitals, pharmaceutical and biotechnology companies, research institutes, and other organizations.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The fast surge in U.S. tariffs and the trade tensions that followed in spring 2025 are heavily affecting the medical equipment sector, particularly for imported imaging machine components, surgical-grade stainless steel, and plastic disposables. Hospitals and clinics resist price hikes, pressuring manufacturers' margins. Regulatory hurdles compound the problem, as tariff-related supplier changes often require re-certification of devices, delaying time-to-market. Companies are mitigating risks by dual-sourcing critical parts, expanding domestic production of commoditized items, and accelerating R&D in cost-efficient materials.

The syndromic multiplex diagnostics market research report is one of a series of new reports from The Business Research Company that provides syndromic multiplex diagnostics market statistics, including the syndromic multiplex diagnostics industry global market size, regional shares, competitors with the syndromic multiplex diagnostics market share, detailed syndromic multiplex diagnostics market segments, market trends, and opportunities, and any further data you may need to thrive in the syndromic multiplex diagnostics industry. This syndromic multiplex diagnostics market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The syndromic multiplex diagnostics market size has grown rapidly in recent years. It will grow from $3.11 billion in 2024 to $3.43 billion in 2025 at a compound annual growth rate (CAGR) of 10.0%. The growth observed during the historic period can be attributed to the increasing demand for rapid and precise diagnostics, greater awareness of early disease detection, a rise in hospital-acquired infections, wider adoption of molecular diagnostics, higher healthcare spending, and an expanding need for point-of-care testing.

The syndromic multiplex diagnostics market size is expected to see strong growth in the next few years. It will grow to $4.96 billion in 2029 at a compound annual growth rate (CAGR) of 9.7%. The growth during the forecast period can be attributed to increasing investments in research and development, greater adoption in low-resource settings, expanding healthcare infrastructure in developing countries, rising government initiatives for infectious disease control, and growing demand for decentralized testing. Key trends in the forecast period include advancements in multiplex polymerase chain reaction (PCR) technologies, innovations in microfluidics and lab-on-chip systems, enhanced automation in sample processing, development of point-of-care molecular platforms, integration of cloud-based diagnostic data systems, and progress in portable diagnostic devices.

The rising prevalence of infectious diseases is anticipated to drive growth in the syndromic multiplex diagnostics market in the coming years. Infectious diseases are caused by harmful microorganisms, including bacteria, viruses, fungi, or parasites, which invade the body, multiply, and cause various symptoms and health complications. The increase in infectious diseases is largely attributed to growing global travel, which facilitates the spread of pathogens across borders and populations. Syndromic multiplex diagnostics support infectious disease management by enabling the rapid and simultaneous detection of multiple pathogens from a single sample. These diagnostics enhance both the speed and accuracy of diagnosis, allowing for timely treatment decisions and improved patient outcomes. For example, in March 2023, the Centers for Disease Control and Prevention, a national public health organization in the United States, reported 8,331 cases of tuberculosis (TB) in 2022, marking a 5.9% rise from 7,874 cases in 2021. Consequently, the growing prevalence of infectious diseases is contributing to the expansion of the syndromic multiplex diagnostics market.

Leading companies in the syndromic multiplex diagnostics sector are concentrating on developing technologically advanced solutions, including AI-powered diagnostic algorithms, to improve the speed, accuracy, and breadth of pathogen detection. AI-enhanced diagnostic algorithms are sophisticated computational tools that use artificial intelligence, particularly machine learning and deep learning methods, to analyze complex clinical and laboratory data for faster and more precise disease diagnosis. For instance, in January 2024, Qiagen N.V., a molecular diagnostics company based in the Netherlands, launched two syndromic testing panels, the Gastrointestinal Panel 2 and the Meningitis and Encephalitis Panel for its QIAstat Dx platform. These panels allow rapid and accurate detection of multiple pathogens in a single test, aiding clinical decision-making and improving patient outcomes. The QIAstat-Dx system also incorporates advanced data analytics, helping healthcare professionals efficiently identify and manage infectious disease outbreaks.

In June 2022, R Biopharm AG, a biotechnology company based in Germany, acquired AusDiagnostics Pty Ltd. for an undisclosed sum. Through this acquisition, R Biopharm aims to expand its product portfolio, enter new clinical diagnostics market segments, and accelerate its international growth strategy, positioning itself as a globally recognized system supplier in laboratory diagnostics across multiple regions. AusDiagnostics Pty Ltd., headquartered in Australia, specializes in in vitro diagnostics (IVD) and syndromic multiplex diagnostics.

Major players in the syndromic multiplex diagnostics market are Roche Molecular Systems Inc., Abbott Laboratories, Becton Dickinson and Company, Hologic Inc., Bio-Rad Laboratories Inc., Qiagen N.V., Cepheid, Bosch Healthcare Solutions GmbH, Biocartis NV, Luminex Corporation, Curetis GmbH, Accelerate Diagnostics Inc., Applied BioCode Inc., Ador Diagnostics Ltd., Akonni Biosystems Inc., Alveo Technologies Inc., Atlas Genetics Ltd., BioFire Diagnostics LLC, Nanomix Inc., Primerdesign Ltd.

North America was the largest region in the syndromic multiplex diagnostics market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in syndromic multiplex diagnostics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the syndromic multiplex diagnostics market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The syndromic multiplex diagnostics market consists of revenues earned by entities by providing services such as diagnostic workflow integration services, remote testing, clinical decision support tools for syndromic testing, and regulatory and compliance support for diagnostic labs. The market value includes the value of related goods sold by the service provider or included within the service offering. The syndromic multiplex diagnostics market also includes sales of multiplex diagnostic instruments, reagents and consumables, software, and accessories used for the simultaneous detection of multiple pathogens. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Syndromic Multiplex Diagnostics Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on syndromic multiplex diagnostics market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for syndromic multiplex diagnostics ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The syndromic multiplex diagnostics market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Product Type: Instruments; Reagents; Software And Services
  • 2) By Sample Type: Blood Samples; Urine Samples; Saliva Samples; Tissue Samples
  • 3) By Technology: Polymerase Chain Reaction; Mass Spectrometry; Nucleic Acid Amplification Tests; Next-Generation Sequencing
  • 4) By Application: Infectious Diseases; Respiratory Diseases; Gastrointestinal Diseases; Sexually Transmitted Infections; Central Nervous System Diseases
  • 5) By End User: Clinical Laboratories; Hospitals; Pharmaceutical And Biotechnology Companies; Research Institutes; Other End Users
  • Subsegments:
  • 1) By Instruments: Real-Time Polymerase Chain Reaction (PCR) Systems; Microfluidic-Based Systems; Automated Sample-To-Answer Systems; Cartridge-Based Systems; Multiplex Polymerase Chain Reaction (PCR) Platforms
  • 2) By Reagents: Assay Panels; Primers And Probes; Enzymes; Buffers And Solutions; Sample Preparation Reagents
  • 3) By Software And Services: Data Analysis Software; Cloud-Based Diagnostic Platforms; Integration And Connectivity Solutions; Technical Support Services; Maintenance And Calibration Services; Training And Installation Services
  • Companies Mentioned: Roche Molecular Systems Inc.; Abbott Laboratories; Becton Dickinson and Company; Hologic Inc.; Bio-Rad Laboratories Inc.; Qiagen N.V.; Cepheid; Bosch Healthcare Solutions GmbH; Biocartis NV; Luminex Corporation; Curetis GmbH; Accelerate Diagnostics Inc.; Applied BioCode Inc.; Ador Diagnostics Ltd.; Akonni Biosystems Inc.; Alveo Technologies Inc.; Atlas Genetics Ltd.; BioFire Diagnostics LLC; Nanomix Inc.; Primerdesign Ltd.
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Syndromic Multiplex Diagnostics Market Characteristics

3. Syndromic Multiplex Diagnostics Market Trends And Strategies

4. Syndromic Multiplex Diagnostics Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

  • 4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Syndromic Multiplex Diagnostics Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Syndromic Multiplex Diagnostics PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Syndromic Multiplex Diagnostics Market Growth Rate Analysis
  • 5.4. Global Syndromic Multiplex Diagnostics Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Syndromic Multiplex Diagnostics Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Syndromic Multiplex Diagnostics Total Addressable Market (TAM)

6. Syndromic Multiplex Diagnostics Market Segmentation

  • 6.1. Global Syndromic Multiplex Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Instruments
  • Reagents
  • Software And Services
  • 6.2. Global Syndromic Multiplex Diagnostics Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Blood Samples
  • Urine Samples
  • Saliva Samples
  • Tissue Samples
  • 6.3. Global Syndromic Multiplex Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Polymerase Chain Reaction
  • Mass Spectrometry
  • Nucleic Acid Amplification Tests
  • Next-Generation Sequencing
  • 6.4. Global Syndromic Multiplex Diagnostics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Infectious Diseases
  • Respiratory Diseases
  • Gastrointestinal Diseases
  • Sexually Transmitted Infections
  • Central Nervous System Diseases
  • 6.5. Global Syndromic Multiplex Diagnostics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Clinical Laboratories
  • Hospitals
  • Pharmaceutical And Biotechnology Companies
  • Research Institutes
  • Other End Users
  • 6.6. Global Syndromic Multiplex Diagnostics Market, Sub-Segmentation Of Instruments, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Real-Time Polymerase Chain Reaction (PCR) Systems
  • Microfluidic-Based Systems
  • Automated Sample-To-Answer Systems
  • Cartridge-Based Systems
  • Multiplex Polymerase Chain Reaction (PCR) Platforms
  • 6.7. Global Syndromic Multiplex Diagnostics Market, Sub-Segmentation Of Reagents, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Assay Panels
  • Primers And Probes
  • Enzymes
  • Buffers And Solutions
  • Sample Preparation Reagents
  • 6.8. Global Syndromic Multiplex Diagnostics Market, Sub-Segmentation Of Software And Services, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Data Analysis Software
  • Cloud-Based Diagnostic Platforms
  • Integration And Connectivity Solutions
  • Technical Support Services
  • Maintenance And Calibration Services
  • Training And Installation Services

7. Syndromic Multiplex Diagnostics Market Regional And Country Analysis

  • 7.1. Global Syndromic Multiplex Diagnostics Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Syndromic Multiplex Diagnostics Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Syndromic Multiplex Diagnostics Market

  • 8.1. Asia-Pacific Syndromic Multiplex Diagnostics Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Syndromic Multiplex Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Syndromic Multiplex Diagnostics Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Syndromic Multiplex Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Syndromic Multiplex Diagnostics Market

  • 9.1. China Syndromic Multiplex Diagnostics Market Overview
  • 9.2. China Syndromic Multiplex Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Syndromic Multiplex Diagnostics Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Syndromic Multiplex Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Syndromic Multiplex Diagnostics Market

  • 10.1. India Syndromic Multiplex Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Syndromic Multiplex Diagnostics Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Syndromic Multiplex Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Syndromic Multiplex Diagnostics Market

  • 11.1. Japan Syndromic Multiplex Diagnostics Market Overview
  • 11.2. Japan Syndromic Multiplex Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Syndromic Multiplex Diagnostics Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Syndromic Multiplex Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Syndromic Multiplex Diagnostics Market

  • 12.1. Australia Syndromic Multiplex Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Syndromic Multiplex Diagnostics Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Syndromic Multiplex Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Syndromic Multiplex Diagnostics Market

  • 13.1. Indonesia Syndromic Multiplex Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Syndromic Multiplex Diagnostics Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Syndromic Multiplex Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Syndromic Multiplex Diagnostics Market

  • 14.1. South Korea Syndromic Multiplex Diagnostics Market Overview
  • 14.2. South Korea Syndromic Multiplex Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Syndromic Multiplex Diagnostics Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Syndromic Multiplex Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Syndromic Multiplex Diagnostics Market

  • 15.1. Western Europe Syndromic Multiplex Diagnostics Market Overview
  • 15.2. Western Europe Syndromic Multiplex Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Syndromic Multiplex Diagnostics Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Syndromic Multiplex Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Syndromic Multiplex Diagnostics Market

  • 16.1. UK Syndromic Multiplex Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Syndromic Multiplex Diagnostics Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Syndromic Multiplex Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Syndromic Multiplex Diagnostics Market

  • 17.1. Germany Syndromic Multiplex Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Syndromic Multiplex Diagnostics Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Syndromic Multiplex Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Syndromic Multiplex Diagnostics Market

  • 18.1. France Syndromic Multiplex Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Syndromic Multiplex Diagnostics Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Syndromic Multiplex Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Syndromic Multiplex Diagnostics Market

  • 19.1. Italy Syndromic Multiplex Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Syndromic Multiplex Diagnostics Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Syndromic Multiplex Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Syndromic Multiplex Diagnostics Market

  • 20.1. Spain Syndromic Multiplex Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Syndromic Multiplex Diagnostics Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Syndromic Multiplex Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Syndromic Multiplex Diagnostics Market

  • 21.1. Eastern Europe Syndromic Multiplex Diagnostics Market Overview
  • 21.2. Eastern Europe Syndromic Multiplex Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Syndromic Multiplex Diagnostics Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Syndromic Multiplex Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Syndromic Multiplex Diagnostics Market

  • 22.1. Russia Syndromic Multiplex Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Syndromic Multiplex Diagnostics Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Syndromic Multiplex Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Syndromic Multiplex Diagnostics Market

  • 23.1. North America Syndromic Multiplex Diagnostics Market Overview
  • 23.2. North America Syndromic Multiplex Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Syndromic Multiplex Diagnostics Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Syndromic Multiplex Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Syndromic Multiplex Diagnostics Market

  • 24.1. USA Syndromic Multiplex Diagnostics Market Overview
  • 24.2. USA Syndromic Multiplex Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Syndromic Multiplex Diagnostics Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Syndromic Multiplex Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Syndromic Multiplex Diagnostics Market

  • 25.1. Canada Syndromic Multiplex Diagnostics Market Overview
  • 25.2. Canada Syndromic Multiplex Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Syndromic Multiplex Diagnostics Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Syndromic Multiplex Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Syndromic Multiplex Diagnostics Market

  • 26.1. South America Syndromic Multiplex Diagnostics Market Overview
  • 26.2. South America Syndromic Multiplex Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Syndromic Multiplex Diagnostics Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Syndromic Multiplex Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Syndromic Multiplex Diagnostics Market

  • 27.1. Brazil Syndromic Multiplex Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Syndromic Multiplex Diagnostics Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Syndromic Multiplex Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Syndromic Multiplex Diagnostics Market

  • 28.1. Middle East Syndromic Multiplex Diagnostics Market Overview
  • 28.2. Middle East Syndromic Multiplex Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Syndromic Multiplex Diagnostics Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Syndromic Multiplex Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Syndromic Multiplex Diagnostics Market

  • 29.1. Africa Syndromic Multiplex Diagnostics Market Overview
  • 29.2. Africa Syndromic Multiplex Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Syndromic Multiplex Diagnostics Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Syndromic Multiplex Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Syndromic Multiplex Diagnostics Market Competitive Landscape And Company Profiles

  • 30.1. Syndromic Multiplex Diagnostics Market Competitive Landscape
  • 30.2. Syndromic Multiplex Diagnostics Market Company Profiles
    • 30.2.1. Roche Molecular Systems Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. Becton Dickinson and Company Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. Hologic Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. Bio-Rad Laboratories Inc. Overview, Products and Services, Strategy and Financial Analysis

31. Syndromic Multiplex Diagnostics Market Other Major And Innovative Companies

  • 31.1. Qiagen N.V.
  • 31.2. Cepheid
  • 31.3. Bosch Healthcare Solutions GmbH
  • 31.4. Biocartis NV
  • 31.5. Luminex Corporation
  • 31.6. Curetis GmbH
  • 31.7. Accelerate Diagnostics Inc.
  • 31.8. Applied BioCode Inc.
  • 31.9. Ador Diagnostics Ltd.
  • 31.10. Akonni Biosystems Inc.
  • 31.11. Alveo Technologies Inc.
  • 31.12. Atlas Genetics Ltd.
  • 31.13. BioFire Diagnostics LLC
  • 31.14. Nanomix Inc.
  • 31.15. Primerdesign Ltd.

32. Global Syndromic Multiplex Diagnostics Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Syndromic Multiplex Diagnostics Market

34. Recent Developments In The Syndromic Multiplex Diagnostics Market

35. Syndromic Multiplex Diagnostics Market High Potential Countries, Segments and Strategies

  • 35.1 Syndromic Multiplex Diagnostics Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Syndromic Multiplex Diagnostics Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Syndromic Multiplex Diagnostics Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer